v3.26.1
Condensed Consolidated Statements of Stockholders' Equity / (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Non controlling Interest [Member]
Begning Balance at Dec. 31, 2024 $ (192,641) $ 1 $ 1 $ 454,614 $ 6,317 $ (563,052) $ (90,522)  
Begning Balance (in shares) at Dec. 31, 2024   34,057 6,952          
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2024             1,716  
Treasury Stock transferred to Tranche B Investors for Tranche B Notes deferral 2,182     (5,353)     $ 7,535  
Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral, Shares             (143)  
Treasury Stock paid for Gloperba Ex-U.S. License 366     (808)     $ 1,174  
Treasury Stock paid for Gloperba Ex-U.S. License, Shares             (22)  
Treasury Stock transferred to Oramed for the Oramed Note maturity extension 1,375     (3,523)     $ 4,898  
Treasury Stock transferred to Oramed for the Oramed Note maturity extension, Shares             (93)  
Stock-based compensation 3,314     3,314        
Net Loss (26,080)         (26,080)    
Ending Balance at Mar. 31, 2025 (211,484) $ 1 $ 1 448,244 6,317 (589,132) $ (76,915)  
Ending Balance (in shares) at Mar. 31, 2025   34,057 6,952          
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2025             1,458  
Begning Balance at Dec. 31, 2024 (192,641) $ 1 $ 1 454,614 6,317 (563,052) $ (90,522)  
Begning Balance (in shares) at Dec. 31, 2024   34,057 6,952          
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2024             1,716  
Other comprehensive Loss 0              
Net Loss (70,128)              
Ending Balance at Jun. 30, 2025 (248,987) $ 1 $ 1 453,049 6,317 (631,440) $ (76,915)  
Ending Balance (in shares) at Jun. 30, 2025   34,057 6,956          
Treasury Stock, Ending Balance (in shares) at Jun. 30, 2025             1,458  
Begning Balance at Mar. 31, 2025 (211,484) $ 1 $ 1 448,244 6,317 (589,132) $ (76,915)  
Begning Balance (in shares) at Mar. 31, 2025   34,057 6,952          
Treasury Stock, Beginning Balance (in shares) at Mar. 31, 2025             1,458  
Acquisition of controlling interest 3,250     1,510       $ 1,740
Shares issued under ESPP, shares     4          
Shares issued under ESPP, Value 17     17        
Payments in lieu of fractional shares or Reverse Stock Split (1)     (1)        
Stock-based compensation 3,279     3,279        
Other comprehensive Loss 0              
Net Loss (44,048)         (42,308)   (1,740)
Ending Balance at Jun. 30, 2025 (248,987) $ 1 $ 1 453,049 6,317 (631,440) $ (76,915)  
Ending Balance (in shares) at Jun. 30, 2025   34,057 6,956          
Treasury Stock, Ending Balance (in shares) at Jun. 30, 2025             1,458  
Begning Balance at Dec. 31, 2025 $ (211,752) $ 1 $ 1 796,721 (5,803) (921,786) $ (76,915) (3,971)
Begning Balance (in shares) at Dec. 31, 2025   34,057 8,491          
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2025 1,458,263           1,458  
Stock dividend declared in 2024, and canceled in February 2026, (shares)   (5,000)            
Stock dividend declared in 2024, and canceled in February 2026   $ (1)   1        
Stockholders' Equity Beginning Balance at Dec. 31, 2025 $ (207,781)              
Acquisition of controlling interest 1,500             1,500
Vivasor - repurchase of shares (1,050)     (1,050)        
Stock-based compensation 3,629     3,629        
Other comprehensive Loss (747)       (747)      
Net Loss (45,650)         (43,270)   (2,380)
Ending Balance at Mar. 31, 2026 (254,070)   $ 1 799,301 (6,550) (965,056) $ (76,915) (4,851)
Ending Balance (in shares) at Mar. 31, 2026   29,057 8,491          
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2026             1,458  
Begning Balance at Dec. 31, 2025 $ (211,752) $ 1 $ 1 796,721 (5,803) (921,786) $ (76,915) (3,971)
Begning Balance (in shares) at Dec. 31, 2025   34,057 8,491          
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2025 1,458,263           1,458  
Stockholders' Equity Beginning Balance at Dec. 31, 2025 $ (207,781)              
Other comprehensive Loss (1,179)              
Net Loss (160,636)              
Ending Balance at Jun. 30, 2026 $ (310,488) $ 0 $ 1 854,130 (6,982) (1,078,556) $ (76,915) (2,166)
Ending Balance (in shares) at Jun. 30, 2026   29,057 8,493          
Treasury Stock, Ending Balance (in shares) at Jun. 30, 2026 1,458,263           1,458  
Stockholders' Equity Ending Balance at Jun. 30, 2026 $ (308,322)              
Begning Balance at Mar. 31, 2026 (254,070)   $ 1 799,301 (6,550) (965,056) $ (76,915) (4,851)
Begning Balance (in shares) at Mar. 31, 2026   29,057 8,491          
Treasury Stock, Beginning Balance (in shares) at Mar. 31, 2026             1,458  
Vivasor - repurchase of shares (1,977)     (1,977)        
Shares issued under ESPP, shares     2          
Shares issued under ESPP, Value 21     21        
Vivasor - shares issued to Datavault 56,197     56,197        
Semnur dividend distribution       (4,171)       4,171
Vivasor - stock-based compensation warrants 1,164     1,164        
Stock-based compensation 3,595     3,595        
Other comprehensive Loss (432)       (432)      
Net Loss (114,986)         (113,500)   (1,486)
Ending Balance at Jun. 30, 2026 $ (310,488) $ 0 $ 1 $ 854,130 $ (6,982) $ (1,078,556) $ (76,915) $ (2,166)
Ending Balance (in shares) at Jun. 30, 2026   29,057 8,493          
Treasury Stock, Ending Balance (in shares) at Jun. 30, 2026 1,458,263           1,458  
Stockholders' Equity Ending Balance at Jun. 30, 2026 $ (308,322)